NCT01974141

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

A Safety and Efficacy Study to Compare Dapsone Dermal Gel With Vehicle Control in Patients With Acne Vulgaris

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 2,102 (actual)
• Sponsor: Almirall, S.A. · Industry
• Sex: All
• Age: 12 Years
• Healthy volunteers: Not accepted

Summary

This study will assess the safety and efficacy of dapsone gel versus vehicle control in patients with acne vulgaris.

Detailed description

This is a multicenter, double-blind, randomized, parallel-group, vehicle-controlled study to assess the safety and efficacy of dapsone 7.5% gel versus vehicle administered topically once daily for 12 weeks in patients with acne vulgaris.

Conditions

• Acne Vulgaris

Interventions

Type	Name	Description
DRUG	Dapsone Gel	Dapsone gel applied topically to the face and to affected areas of the trunk once daily for 12 weeks.
DRUG	Dapsone Gel Vehicle	Dapsone gel vehicle applied topically to the face and to affected areas of the trunk once daily for 12 weeks.

Timeline

• Start date: 2013-11-01
• Primary completion: 2014-10-01
• Completion: 2014-10-01
• First posted: 2013-11-01
• Last updated: 2018-10-09
• Results posted: 2017-02-06

Locations

2 sites across 2 countries: United States, Canada